KPIs & Operating Metrics(New)
Biopharma Testing VolumeBreakdown Of AssetsClinical VolumeContractual ObligationsCost Of RevenueCost Of Revenue By SegmentDeferred RevenueEmployee StatisticsGross Margin %Gross Margin By Segment %Gross ProfitGross Profit By SegmentIncome Before Provision For Income TaxesNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Opex As A % Of RevenueOPEX BreakdownProperty And Equipment, NetRevenueRevenue By RegionRevenue By Region %Revenue By Region AnnualRevenue By Region Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) Revenue (2017 - 2025)

Guardant Health's Revenue history spans 9 years, with the latest figure at $281.3 million for Q4 2025.

  • For Q4 2025, Revenue rose 39.37% year-over-year to $281.3 million; the TTM value through Dec 2025 reached $982.0 million, up 32.88%, while the annual FY2025 figure was $982.0 million, 32.88% up from the prior year.
  • Revenue for Q4 2025 was $281.3 million at Guardant Health, up from $265.2 million in the prior quarter.
  • Across five years, Revenue topped out at $281.3 million in Q4 2025 and bottomed at $78.7 million in Q1 2021.
  • The 5-year median for Revenue is $140.1 million (2023), against an average of $155.4 million.
  • The largest annual shift saw Revenue grew 16.52% in 2021 before it surged 39.37% in 2025.
  • A 5-year view of Revenue shows it stood at $108.1 million in 2021, then increased by 17.37% to $126.9 million in 2022, then increased by 22.19% to $155.1 million in 2023, then soared by 30.16% to $201.8 million in 2024, then surged by 39.37% to $281.3 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Revenue are $281.3 million (Q4 2025), $265.2 million (Q3 2025), and $232.1 million (Q2 2025).